These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 1767085

  • 1. [Therapeutic advances in glomerular nephropathies].
    Pérez García R.
    Rev Clin Esp; 1991 Nov; 189(7):305-8. PubMed ID: 1767085
    [No Abstract] [Full Text] [Related]

  • 2. [Immunotherapy of primary glomerulonephritis].
    Ritz E, Mickisch O.
    Internist (Berl); 1989 Mar; 30(3):180-95. PubMed ID: 2654060
    [No Abstract] [Full Text] [Related]

  • 3. [Is there a specific therapy for primary glomerulonephritis?].
    Risler T, Krämer B, Müller GA.
    Dtsch Med Wochenschr; 1989 Jan 20; 114(3):83-4. PubMed ID: 2912678
    [No Abstract] [Full Text] [Related]

  • 4. [Primary and secondary glomerular diseases].
    Birck R, Banas B.
    Dtsch Med Wochenschr; 2011 Apr 20; 136(14):703-5. PubMed ID: 21448831
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of glomerulonephritis in the elderly.
    Kunis CL, Teng SN.
    Semin Nephrol; 2000 May 20; 20(3):256-64. PubMed ID: 10855935
    [Abstract] [Full Text] [Related]

  • 6. [Idiopathic nephrotic syndrome].
    Belovezhdov N.
    Vutr Boles; 1984 May 20; 23(4):14-21. PubMed ID: 6390968
    [No Abstract] [Full Text] [Related]

  • 7. Primary glomerulonephritides with nephrotic syndrome. Limitations of therapy in adult patients.
    Schena FP.
    J Nephrol; 1999 May 20; 12 Suppl 2():S125-30. PubMed ID: 10688412
    [Abstract] [Full Text] [Related]

  • 8. CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.
    Mariani LH, Bomback AS, Canetta PA, Flessner MF, Helmuth M, Hladunewich MA, Hogan JJ, Kiryluk K, Nachman PH, Nast CC, Rheault MN, Rizk DV, Trachtman H, Wenderfer SE, Bowers C, Hill-Callahan P, Marasa M, Poulton CJ, Revell A, Vento S, Barisoni L, Cattran D, D'Agati V, Jennette JC, Klein JB, Laurin LP, Twombley K, Falk RJ, Gharavi AG, Gillespie BW, Gipson DS, Greenbaum LA, Holzman LB, Kretzler M, Robinson B, Smoyer WE, Guay-Woodford LM, CureGN Consortium.
    Am J Kidney Dis; 2019 Feb 20; 73(2):218-229. PubMed ID: 30420158
    [Abstract] [Full Text] [Related]

  • 9. New diagnostic tests and new therapies for glomerular diseases.
    Appel GB, Appel AS.
    Blood Purif; 2013 Feb 20; 35(1-3):81-5. PubMed ID: 23343551
    [Abstract] [Full Text] [Related]

  • 10. Nephrotic syndrome in childhood. Management and treatment in patients with minimal change disease, mesangial proliferation, or focal glomerulosclerosis.
    McEnery PT, Strife CF.
    Pediatr Clin North Am; 1982 Aug 20; 29(4):875-94. PubMed ID: 7050865
    [No Abstract] [Full Text] [Related]

  • 11. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?
    Muso E, Yashiro M, Matsushima M, Yoshida H, Sawanishi K, Sasayama S.
    Nephrol Dial Transplant; 1994 Aug 20; 9(3):257-64. PubMed ID: 8052431
    [Abstract] [Full Text] [Related]

  • 12. Glomerulonephritis--management in general practice.
    Isbel NM.
    Aust Fam Physician; 2005 Nov 20; 34(11):907-13. PubMed ID: 16299623
    [Abstract] [Full Text] [Related]

  • 13. What is new in therapy of glomerulonephritis in 2003/2004.
    Hruby Z.
    Rocz Akad Med Bialymst; 2004 Nov 20; 49():166-9. PubMed ID: 15631335
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of primary glomerulonephritis].
    Nagy J.
    Orv Hetil; 2005 Jan 23; 146(4):169-73. PubMed ID: 15751512
    [No Abstract] [Full Text] [Related]

  • 15. [Epidemiology of chronic glomerular diseases].
    Stengel B.
    Rev Prat; 2003 Nov 30; 53(18):1993-7. PubMed ID: 15008212
    [Abstract] [Full Text] [Related]

  • 16. Glomerular disease made easier: 2.
    Robertson S, Isles C, More I.
    Br J Hosp Med; 2003 Nov 30; 53(7):323-6. PubMed ID: 7788069
    [No Abstract] [Full Text] [Related]

  • 17. Therapeutic trial of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS).
    Tojo K, Sakai S, Miyahara T.
    Prog Clin Biol Res; 1990 Nov 30; 337():193-4. PubMed ID: 2191313
    [No Abstract] [Full Text] [Related]

  • 18. [The treatment of glomerulonephritis (author's transl)].
    Thiel G.
    Ther Umsch; 1982 May 30; 39(5):341-50. PubMed ID: 7101214
    [No Abstract] [Full Text] [Related]

  • 19. [Histological classification of chronic glomerular diseases].
    Noël LH, Gubler MC.
    Rev Prat; 2003 Nov 30; 53(18):2005-12. PubMed ID: 15008214
    [Abstract] [Full Text] [Related]

  • 20. [Minimal change glomerulonephritis, diffuse mesangioproliferative glomerulonephritis and focal and segmental glomerular sclerosis and hyalinosis].
    Belovezhdov N.
    Vutr Boles; 1984 Nov 30; 23(4):42-6. PubMed ID: 6506660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.